New engineering leader accelerates Secuvy's mission to solve the hardest data challenges enterprises face before their ...
The updated analyst work on OptimizeRx centers on a sharp reset in the stock’s fair value estimate, with the price target revised from US$24.33 to US$14.50, a cut of roughly 40%. That shift lines up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results